Concord Biotech Limited (BOM:543960)
India
· Delayed Price · Currency is INR 1,638.30
-61.60 (-3.62%)
At close: Aug 6, 2025
Concord Biotech Revenue
Concord Biotech had revenue of 2.04B INR in the quarter ending June 30, 2025, a decrease of -5.47%. This brings the company's revenue in the last twelve months to 11.88B, up 14.49% year-over-year. In the fiscal year ending March 31, 2025, Concord Biotech had annual revenue of 12.00B with 18.01% growth.
Revenue (ttm)
11.88B
Revenue Growth
+14.49%
P/S Ratio
14.46
Revenue / Employee
7.56M
Employees
1,377
Market Cap
171.83B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| HDFC Bank | 2,736.06B |
| Bharti Airtel | 1,839.41B |
| Tata Consultancy Services | 2,561.48B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,503.84B |
| Infosys | 1,672.76B |
| Hindustan Unilever | 639.28B |